Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (CDX1307-02)

This study has been completed.
Sponsor:
Information provided by:
Celldex Therapeutics
ClinicalTrials.gov Identifier:
NCT00648102
First received: March 28, 2008
Last updated: July 23, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)